Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ironwood Pharmaceuticals Inc (IRWD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ironwood Pharmaceuticals Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1446847.
Total stock buying since 2015: $23,429,816.
Total stock sales since 2015: $62,104,157.
Total stock option exercises since 2015: $19,222,669.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 259,115 | $440,886 | 0 | $0 |
| 2024 | 17,604 | $160,418 | 536,935 | $5,863,374 | 0 | $0 |
| 2023 | 36,072 | $300,119 | 624,085 | $7,224,142 | 332,886 | $3,878,121 |
| 2022 | 0 | $0 | 581,591 | $6,752,594 | 208,424 | $2,428,138 |
| 2021 | 2,365,000 | $22,969,279 | 284,297 | $3,055,230 | 0 | $0 |
| 2020 | 0 | $0 | 277,980 | $3,254,706 | 258,076 | $2,511,317 |
| 2019 | 0 | $0 | 652,884 | $7,613,387 | 370,449 | $1,809,094 |
| 2018 | 0 | $0 | 579,710 | $10,369,251 | 547,852 | $4,061,750 |
| 2017 | 0 | $0 | 362,736 | $5,987,975 | 458,372 | $1,647,166 |
| 2016 | 0 | $0 | 315,282 | $3,546,799 | 855,655 | $1,814,523 |
| 2015 | 0 | $0 | 536,505 | $7,995,813 | 803,223 | $1,072,560 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-10 | Consylman Gina (SVP, CFO & Treasurer) | Sale | 4,055 | 10.53 | 42,699 |
| 2019-05-10 | Mccourt Thomas A (President) | Sale | 4,055 | 10.53 | 42,699 |
| 2019-05-10 | Currie Mark G (Director) | Sale | 4,055 | 10.53 | 42,699 |
| 2019-03-08 | Currie Mark G (Chief Scientific Officer) | Sale | 49,500 | 13.15 | 650,925 |
| 2019-03-07 | Currie Mark G (Chief Scientific Officer) | Sale | 225,500 | 13.29 | 2,996,895 |
| 2019-03-05 | Mchugh Julie (Director) | Sale | 1,500 | 14.38 | 21,570 |
| 2019-03-05 | Olanoff Lawrence S (Director) | Sale | 2,000 | 14.41 | 28,820 |
| 2019-02-21 | Gilbert Halley E (Chief Legal Officer) | Sale | 85 | 14.32 | 1,217 |
| 2019-02-21 | Consylman Gina (Chief Financial Officer) | Sale | 46 | 14.32 | 658 |
| 2019-02-21 | Mccourt Thomas A (Chief Commercial Officer) | Sale | 41 | 14.32 | 587 |
| 2019-02-21 | Currie Mark G (Chief Scientific Officer) | Sale | 13 | 14.32 | 186 |
| 2019-02-20 | Gilbert Halley E (Chief Legal Officer) | Sale | 10,157 | 14.31 | 145,346 |
| 2019-02-20 | Consylman Gina (Chief Financial Officer) | Sale | 5,631 | 14.31 | 80,579 |
| 2019-02-20 | Mccourt Thomas A (Chief Commercial Officer) | Sale | 4,800 | 14.31 | 68,688 |
| 2019-02-20 | Currie Mark G (Chief Scientific Officer) | Sale | 1,631 | 14.31 | 23,339 |
| 2019-01-30 | Gilbert Halley E (Chief Legal Officer) | Option Ex | 20,449 | 4.89 | 99,995 |
| 2019-01-25 | Hecht Peter M (Chief Executive Officer) | Sale | 29,551 | 12.23 | 361,408 |
| 2019-01-25 | Hecht Peter M (Chief Executive Officer) | Option Ex | 50,000 | 4.89 | 244,499 |
| 2019-01-24 | Hecht Peter M (Chief Executive Officer) | Sale | 30,000 | 12.70 | 381,000 |
| 2019-01-24 | Hecht Peter M (Chief Executive Officer) | Option Ex | 30,000 | 4.89 | 146,700 |
| 2019-01-23 | Hecht Peter M (Chief Executive Officer) | Sale | 30,000 | 12.66 | 379,800 |
| 2019-01-23 | Hecht Peter M (Chief Executive Officer) | Option Ex | 30,000 | 4.89 | 146,700 |
| 2018-12-06 | Mchugh Julie (Director) | Sale | 1,500 | 12.46 | 18,690 |
| 2018-12-06 | Olanoff Lawrence S (Director) | Sale | 2,000 | 12.47 | 24,940 |
| 2018-11-09 | Consylman Gina (Chief Financial Officer) | Sale | 1,358 | 11.81 | 16,037 |
| 2018-10-05 | Currie Mark G (Chief Scientific Officer) | Sale | 116,651 | 17.53 | 2,044,892 |
| 2018-10-05 | Currie Mark G (Chief Scientific Officer) | Option Ex | 116,651 | 10.87 | 1,267,646 |
| 2018-10-04 | Currie Mark G (Chief Scientific Officer) | Sale | 116,650 | 18.34 | 2,139,944 |
| 2018-10-04 | Currie Mark G (Chief Scientific Officer) | Option Ex | 116,650 | 10.87 | 1,267,635 |
| 2018-09-05 | Mchugh Julie (Director) | Sale | 1,500 | 19.10 | 28,650 |
| 2018-09-05 | Olanoff Lawrence S (Director) | Sale | 2,000 | 19.10 | 38,200 |
| 2018-08-24 | Currie Mark G (Chief Scientific Officer) | Sale | 65,000 | 18.39 | 1,195,350 |
| 2018-08-24 | Currie Mark G (Chief Scientific Officer) | Option Ex | 65,000 | 5.09 | 330,655 |
| 2018-08-23 | Currie Mark G (Chief Scientific Officer) | Sale | 65,000 | 18.39 | 1,195,350 |
| 2018-08-23 | Currie Mark G (Chief Scientific Officer) | Option Ex | 65,000 | 5.09 | 330,655 |
| 2018-08-22 | Currie Mark G (Chief Scientific Officer) | Sale | 65,000 | 18.51 | 1,203,150 |
| 2018-08-22 | Currie Mark G (Chief Scientific Officer) | Option Ex | 65,000 | 5.09 | 330,655 |
| 2018-08-17 | Consylman Gina (Chief Financial Officer) | Sale | 188 | 18.21 | 3,423 |
| 2018-07-06 | Mccourt Thomas A (Chief Commercial Officer) | Sale | 30,000 | 20.00 | 600,000 |
| 2018-07-06 | Mccourt Thomas A (Chief Commercial Officer) | Option Ex | 30,000 | 5.48 | 164,400 |
| 2018-07-03 | Gilbert Halley E (Chief Legal Officer) | Sale | 29,551 | 19.75 | 583,632 |
| 2018-07-03 | Gilbert Halley E (Chief Legal Officer) | Option Ex | 29,551 | 4.89 | 144,504 |
| 2018-06-05 | Mchugh Julie (Director) | Sale | 1,500 | 17.62 | 26,430 |
| 2018-06-05 | Olanoff Lawrence S (Director) | Sale | 2,000 | 17.62 | 35,240 |
| 2018-03-05 | Mchugh Julie (Director) | Sale | 1,500 | 14.06 | 21,090 |
| 2018-03-05 | Olanoff Lawrence S (Director) | Sale | 2,000 | 14.05 | 28,100 |
| 2018-02-21 | Gilbert Halley E (Chief Legal Officer) | Sale | 7,741 | 14.66 | 113,483 |
| 2018-02-21 | Consylman Gina (Chief Financial Officer) | Sale | 3,594 | 14.66 | 52,688 |
| 2018-02-21 | Mccourt Thomas A (Chief Commercial Officer) | Sale | 3,343 | 14.66 | 49,008 |
| 2018-02-21 | Currie Mark G (Chief Scientific Officer) | Sale | 1,634 | 14.66 | 23,954 |
| 2018-01-24 | Currie Mark G (Chief Scientific Officer) | Sale | 60,000 | 15.45 | 927,000 |
| 2018-01-24 | Currie Mark G (Chief Scientific Officer) | Option Ex | 60,000 | 3.76 | 225,600 |
| 2017-12-07 | Hecht Peter M (Chief Executive Officer) | Sale | 57,405 | 15.00 | 861,075 |
| 2017-12-07 | Hecht Peter M (Chief Executive Officer) | Option Ex | 57,405 | 3.76 | 215,842 |
| 2017-12-06 | Hecht Peter M (Chief Executive Officer) | Sale | 56,000 | 15.24 | 853,440 |
| 2017-12-06 | Hecht Peter M (Chief Executive Officer) | Option Ex | 82,595 | 3.76 | 310,557 |
| 2017-12-04 | Mchugh Julie (Director) | Sale | 1,500 | 16.45 | 24,675 |
| 2017-12-04 | Olanoff Lawrence S (Director) | Sale | 2,000 | 16.29 | 32,570 |
| 2017-09-05 | Mchugh Julie (Director) | Sale | 1,500 | 16.16 | 24,240 |
| 2017-09-05 | Olanoff Lawrence S (Director) | Sale | 2,000 | 16.15 | 32,299 |
| 2017-08-18 | Consylman Gina (Chief Accounting Officer) | Sale | 207 | 14.34 | 2,968 |
| 2017-06-22 | Gilbert Halley E (Chief Legal Officer) | Sale | 35,000 | 19.75 | 691,250 |
| 2017-06-22 | Gilbert Halley E (Chief Legal Officer) | Option Ex | 35,000 | 3.76 | 131,600 |
| 2017-06-08 | Olanoff Lawrence S (Director) | Sale | 3,200 | 17.78 | 56,896 |
| 2017-05-15 | Mccourt Thomas A (Chief Commercial Officer) | Sale | 30,000 | 18.20 | 546,000 |
| 2017-05-15 | Mccourt Thomas A (Chief Commercial Officer) | Option Ex | 30,000 | 5.48 | 164,400 |
| 2017-03-14 | Currie Mark G (Chief Scientific Officer) | Sale | 60,000 | 17.06 | 1,023,599 |
| 2017-03-14 | Currie Mark G (Chief Scientific Officer) | Option Ex | 60,000 | 3.76 | 225,600 |
| 2017-02-22 | Graney Thomas (Chief Financial Officer) | Sale | 1,874 | 16.94 | 31,745 |
| 2017-02-22 | Gilbert Halley E (Chief Legal Officer) | Sale | 5,039 | 16.94 | 85,360 |
| 2017-02-22 | Consylman Gina (Chief Accounting Officer) | Sale | 1,839 | 16.94 | 31,152 |
| 2017-02-22 | Currie Mark G (Chief Scientific Officer) | Sale | 1,800 | 16.94 | 30,492 |
| 2017-02-14 | Gilbert Halley E (Chief Legal Officer) | Sale | 37,385 | 16.75 | 626,198 |
| 2017-02-14 | Gilbert Halley E (Chief Legal Officer) | Option Ex | 37,385 | 3.76 | 140,567 |
| 2017-01-18 | Currie Mark G (Chief Scientific Officer) | Option Ex | 55,987 | 2.94 | 164,601 |
| 2017-01-12 | Hecht Peter M (Chief Executive Officer) | Sale | 32,994 | 15.50 | 511,407 |
| 2017-01-12 | Hecht Peter M (Chief Executive Officer) | Option Ex | 32,994 | 2.94 | 97,002 |
| 2017-01-11 | Hecht Peter M (Chief Executive Officer) | Sale | 32,993 | 15.84 | 522,609 |
| 2017-01-11 | Hecht Peter M (Chief Executive Officer) | Option Ex | 32,993 | 2.94 | 96,999 |
| 2017-01-06 | Currie Mark G (Chief Scientific Officer) | Option Ex | 34,013 | 2.94 | 99,998 |
| 2016-12-05 | Olanoff Lawrence S (Director) | Sale | 3,200 | 15.68 | 50,176 |
| 2016-11-11 | Gilbert Halley E (Chief Legal Officer) | Sale | 14,000 | 16.75 | 234,500 |
| 2016-11-11 | Gilbert Halley E (Chief Legal Officer) | Option Ex | 14,000 | 3.76 | 52,640 |
| 2016-10-31 | Currie Mark G (Chief Scientific Officer) | Option Ex | 300,000 | 2.94 | 882,000 |
| 2016-09-06 | Olanoff Lawrence S (Director) | Sale | 3,200 | 13.72 | 43,904 |
| 2016-08-19 | Consylman Gina (Chief Accounting Officer) | Sale | 207 | 13.54 | 2,802 |
| 2016-06-03 | Olanoff Lawrence S (Director) | Sale | 2,200 | 12.92 | 28,424 |
| 2016-05-25 | Gilbert Halley E (Chief Legal Officer) | Sale | 20,275 | 12.19 | 247,152 |
| 2016-05-25 | Gilbert Halley E (Chief Legal Officer) | Option Ex | 15,865 | 3.76 | 59,652 |
| 2016-03-11 | Hecht Peter M (Chief Executive Officer) | Sale | 40,000 | 10.66 | 426,400 |
| 2016-03-11 | Hecht Peter M (Chief Executive Officer) | Option Ex | 40,000 | 1.56 | 62,400 |
| 2016-03-10 | Hecht Peter M (Chief Executive Officer) | Sale | 40,000 | 10.63 | 425,200 |
| 2016-03-10 | Hecht Peter M (Chief Executive Officer) | Option Ex | 40,000 | 1.56 | 62,400 |
| 2016-03-09 | Hecht Peter M (Chief Executive Officer) | Sale | 40,000 | 10.87 | 434,799 |
| 2016-03-09 | Hecht Peter M (Chief Executive Officer) | Option Ex | 220,790 | 1.56 | 344,432 |
| 2016-03-09 | Currie Mark G (Chief Scientific Officer) | Sale | 150,000 | 10.86 | 1,629,000 |
| 2016-03-09 | Currie Mark G (Chief Scientific Officer) | Option Ex | 160,898 | 1.56 | 251,000 |
| 2016-03-07 | Olanoff Lawrence S (Director) | Sale | 2,200 | 11.11 | 24,442 |
| 2016-01-04 | Currie Mark G (Chief Scientific Officer) | Option Ex | 64,102 | 1.56 | 99,999 |
| 2015-12-15 | Hecht Peter M (Chief Executive Officer) | Sale | 73,418 | 11.07 | 812,737 |
| 2015-12-11 | Hecht Peter M (Chief Executive Officer) | Option Ex | 250,000 | 1.56 | 390,000 |
| 2015-12-07 | Olanoff Lawrence S (Director) | Sale | 2,200 | 11.77 | 25,894 |
| 2015-10-28 | Hecht Peter M (Chief Executive Officer) | Option Ex | 98,115 | 2.02 | 198,192 |
| 2015-09-04 | Olanoff Lawrence S (Director) | Sale | 3,725 | 10.97 | 40,863 |
| 2015-03-18 | Fanucci Marsha (Director) | Sale | 31,339 | 15.68 | 491,395 |
| 2015-03-17 | Hecht Peter M (Chief Executive Officer) | Sale | 125,000 | 15.69 | 1,961,250 |
| 2015-03-17 | Hecht Peter M (Chief Executive Officer) | Option Ex | 125,000 | 1.56 | 195,000 |
| 2015-03-16 | Hecht Peter M (Chief Executive Officer) | Sale | 75,000 | 15.60 | 1,170,000 |
| 2015-03-16 | Hecht Peter M (Chief Executive Officer) | Option Ex | 75,000 | 1.56 | 117,000 |
| 2015-03-12 | Cook Joseph C Jr (Director) | Sale | 3,283 | 15.54 | 51,017 |
| 2015-03-11 | Cook Joseph C Jr (Director) | Sale | 2,600 | 15.53 | 40,378 |
| 2015-03-10 | Roberts Bryan E (Director) | Sale | 89,350 | 15.14 | 1,352,490 |
| 2015-03-09 | Roberts Bryan E (Director) | Sale | 6,648 | 15.63 | 103,888 |
| 2015-03-03 | Hecht Peter M (Chief Executive Officer) | Sale | 6,200 | 15.71 | 97,402 |
| 2015-03-03 | Hecht Peter M (Chief Executive Officer) | Option Ex | 6,200 | 1.56 | 9,672 |
| 2015-03-02 | Hecht Peter M (Chief Executive Officer) | Sale | 13,908 | 16.00 | 222,528 |
| 2015-03-02 | Hecht Peter M (Chief Executive Officer) | Option Ex | 13,908 | 1.56 | 21,696 |
| 2015-02-27 | Hecht Peter M (Chief Executive Officer) | Sale | 43,334 | 15.70 | 680,343 |
| 2015-02-27 | Hecht Peter M (Chief Executive Officer) | Option Ex | 210,000 | .60 | 126,000 |
| 2015-02-20 | Cook Joseph C Jr (Director) | Sale | 2,600 | 15.63 | 40,638 |
| 2015-02-19 | Currie Mark G (Chief Scientific Officer) | Sale | 25,000 | 15.67 | 391,750 |
| 2015-02-19 | Currie Mark G (Chief Scientific Officer) | Option Ex | 25,000 | .60 | 15,000 |
| 2015-02-19 | Cook Joseph C Jr (Director) | Sale | 32,900 | 15.60 | 513,240 |
Insider trading activities including stock purchases, stock sales, and option exercises of IRWD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ironwood Pharmaceuticals Inc (symbol IRWD, CIK number 1446847) see the Securities and Exchange Commission (SEC) website.